BELSOMRA for insomnia

Belsomra box.png
Belsomra box.png

BELSOMRA for insomnia

0.00

FDA approved BELSOMRA based on the results of two trials that included 1,266 healthy adults. People in the studies had to sleep less than 6.5 hours a night and take more than 30 minutes to fall asleep for at least 3 nights a week during a month or more. Participants were an average age of 56, and 64 percent were women. They were randomly given either BELSOMRA or placebo nightly for 3 months. Get the DrugFactsBox to see what happened. 

Read about Consumer Reports' take on BELSOMRA here.

Add To Cart